Abstract:Qiong Ge, 1, &ast Zhewen Zhang, 2, &ast Zhiming Cao, 2 Dan Wu, 3 Changping Xu, 1 Jianbiao Yao, 3 Jian Gao, 1 Yan Feng 1 1 Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, People's Republic of China; 2 College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China; 3 Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Pharmaceutical Technology, Zhejiang Conba Pharmaceutical Co., Ltd, Hangzhou, Zhejiang, 310057, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Feng, Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, People's Republic of China, Tel/Fax +86-571-87115204, Email Purpose: This study aims to investigate the in vitro antiviral effects of the aqueous solution of Changyanning (CYN) tablets on Enterovirus 71 (EV71), and to analyze its active components. Methods: The in vitro anti-EV71 effects of CYN solution and its herbal ingredients were assessed by testing the relative viral RNA (vRNA) expression level and the cell viability rates. Material basis analysis was performed using HPLC-Q-TOF-MS/MS detection. Potential targets and active components were identified by network pharmacology and molecular docking. The screened components were verified by in vitro antiviral experiments. Results: CYN solution exerted anti-EV71 activities as the vRNA is markedly reduced after treatment, with a half maximal inhibitory concentration (IC 50 ) of 996.85 μg/mL. Of its five herbal ingredients, aqueous extract of Mosla chinensis (AEMC) and leaves of Liquidambar formosana Hance (AELLF) significantly inhibited the intracellular replication of EV71, and the IC 50 was tested as 202.57 μg/mL and 174.77 μg/mL, respectively. Based on HPLC-Q-TOF-MS/MS results, as well as the comparison with the material basis of CYN solution, a total of 44 components were identified from AEMC and AELLF. Through network pharmacology, AKT1, ALB, and SRC were identified as core targets. Molecular docking performed between core targets and the components indicated that 21 components may have anti-EV71 effects. Of these, nine were selected for in vitro pharmacodynamic verification, and only rosmarinic acid manifested in vitro anti-EV71 activity, with an IC 50 of 11.90 μg/mL. Moreover, rosmarinic acid can stably bind with three core targets by forming hydrogen bonds. Conclusion: CYN solution has inhibitory effects on EV71 replication in vitro, and its active component was identified as rosmarinic acid. Our study provides a new approach for screening and confirmation of the effective components in Chinese herbal preparation. Keywords: antiviral effects, material basis analysis, component-target-pathway-disease network, protein–protein interaction network, core targets, rosmarinic acid Enterovirus 71 (EV71) is the main pathogen causing hand, foot, and mouth disease (HFMD). 1 Since 1997, HFMD has emerged as a serious childhood infection in the Asia-Pacific region. 2 From 2008 to July 2022, up to 26.1 million cases of HFMD and 3727 deaths had been reported in China. The disease became a serious public health problem. 3 Although the main manifestations of HFMD are low-grade fever, maculopapular or papular blistering rash on the hands, feet, and mouth ulcers, 4 there were growing evidences that a large number of patients with HFMD have atypical presentations, especially those infected with the EV71, and may rapidly develop serious complications such as encephalitis, pulmonary edema, and myocarditis. 5,6 With the use of EV71 vaccine, 1,7 severe HFMD cases had significantly decreased in China. 8 However, vaccination does not completely prevent viral infection, and some children who were vaccinated may still be infected and develop complications such as encephalitis. 9 At present, no antiviral drug was approved for the treatment of EV71 infection. Moreover, as enterovirus belongs to a non-envelope virus, it is difficult to be killed in the host environment. 10 Therefore, the constant search for effective medicine is essential for the control of the infection caused by EV71. The therapeutic effects of Traditional Chinese medicine (TCM) on infectious disea -Abstract Truncated-

Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors

Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

Antiviral Activity of Rhein against Enterovirus 71 through Inhibiting Viral Replication and Stability

Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment

Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo

Exploration of the in vitro Antiviral Effects and the Active Components of Changyanning Tablets Against Enterovirus 71

Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2

Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses

Honeysuckle-encoded microRNA2911 inhibits Enterovirus 71 replication via targeting VP1 gene

Antiviral Activity of Shikonin Ester Derivative PMM-034 Against Enterovirus 71 in Vitro

Inhibition of Enterovirus 71 Replication by an Α-Hydroxy-nitrile Derivative NK-1.9k

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71

Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication

Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71

Antiviral Mechanisms of Saucerneol from Saururus chinensis against Enterovirus A71, Coxsackievirus A16, and Coxsackievirus B3: Role of Mitochondrial ROS and the STING/TKB-1/IRF3 Pathway

Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization

Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid

Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating

In Vitro and in Vivo Protection Against Enterovirus 71 by an Antisense Phosphorothioate Oligonucleotide